|
76
|
261
|
3d2kA |
Crystal structure of mouse aurora a (asn186->gly, lys240->arg, met302->leu) in complex with [7-(2-{2-[3-(3-chloro-phenyl)-ureido]-thiazol-5-yl}-ethylamino)-pyrazolo[4,3-d]pyrimidin-1-yl]-acetic acid |
|
71
|
282
|
3dbqA |
Crystal structure of ttk kinase domain |
|
73
|
287
|
3dbeA |
Crystal structure of an activated (thr->asp) polo-like kinase 1 (plk1) catalytic domain in complex with compound 557 |
|
70
|
267
|
3cokA |
Crystal structure of plk4 kinase |
|
196
|
641
|
3cikA |
Human grk2 in complex with gbetagamma subunits |
|
97
|
310
|
3cpbA |
Crystal structure of the vegfr2 kinase domain in complex with a bisamide inhibitor |
|
96
|
312
|
3cp9A |
Crystal structure of the vegfr2 kinase domain in complex with a pyridone inhibitor |
|
103
|
348
|
3ctqA |
Structure of map kinase p38 in complex with a 1-o-tolyl-1,2,3-triazole-4-carboxamide |
|
84
|
310
|
3ctjA |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a aminopyridine based inhibitor |
|
80
|
309
|
3cthA |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a aminopyridine based inhibitor |
|
85
|
270
|
3comA |
Crystal structure of mst1 kinase |
|
81
|
279
|
3ckwA |
Crystal structure of sterile 20-like kinase 3 (mst3, stk24) |
|
105
|
330
|
3csvA |
Crystal structure of a putative aminoglycoside phosphotransferase (yp_614837.1) from silicibacter sp. tm1040 at 2.15 a resolution |
|
83
|
281
|
3cr0A |
Wee1 kinase complex with inhibitor pd259_809 |
|
91
|
299
|
3cjgA |
Crystal structure of vegfr2 in complex with a 3,4,5-trimethoxy aniline containing pyrimidine |
|
94
|
335
|
3cquA |
Crystal structure of akt-1 complexed with substrate peptide and inhibitor |
|
102
|
352
|
3coiA |
Crystal structure of p38delta kinase |
|
89
|
305
|
3clyA |
Crystal structure of fgf receptor 2 (fgfr2) kinase domains trapped in trans-phosphorylation reaction |
|
89
|
298
|
3cjfA |
Crystal structure of vegfr2 in complex with a 3,4,5-trimethoxy aniline containing pyrimidine |
|
83
|
278
|
3cqeA |
Wee1 kinase complex with inhibitor pd074291 |
|
95
|
309
|
3cpcA |
Crystal structure of the vegfr2 kinase domain in complex with a pyridone inhibitor |
|
79
|
261
|
3cohA |
Crystal structure of aurora-a in complex with a pentacyclic inhibitor |
|
84
|
279
|
3ckxA |
Crystal structure of sterile 20-like kinase 3 (mst3, stk24) in complex with staurosporine |
|
85
|
268
|
3cs9A |
Human abl kinase in complex with nilotinib |
|
98
|
335
|
3cqwA |
Crystal structure of akt-1 complexed with substrate peptide and inhibitor |
|
108
|
361
|
3byvA |
Crystal structure of toxoplasma gondii specific rhoptry antigen kinase domain |
|
94
|
301
|
3c7qA |
Structure of vegfr2 kinase domain in complex with bibf1120 |
|
114
|
376
|
3cblA |
Crystal structure of human feline sarcoma viral oncogene homologue (v-fes) in complex with staurosporine and a consensus peptide |
|
132
|
503
|
3c51A |
Crystal structure of g protein coupled receptor kinase 1 bound to adp and magnesium chloride at 3.55a |
|
162
|
503
|
3c4zA |
Crystal structure of g protein coupled receptor kinase 1 bound to adp and magnesium chloride at 1.84a |
|
79
|
273
|
3c4eA |
Pim-1 kinase domain in complex with 3-aminophenyl-7-azaindole |
|
95
|
300
|
3c0hA |
Cask cam-kinase domain- amppnp complex, p1 form |
|
74
|
280
|
3cekA |
Crystal structure of human dual specificity protein kinase (ttk) |
|
112
|
328
|
3c13A |
Low ph-value crystal structure of emodin in complex with the catalytic subunit of protein kinase ck2 |
|
99
|
356
|
3cgfA |
Irak-4 inhibitors (part ii)- a structure based assessment of imidazo[1,2 a]pyridine binding |
|
95
|
278
|
3cc6A |
Crystal structure of kinase domain of protein tyrosine kinase 2 beta (ptk2b) |
|
97
|
349
|
3c5uA |
P38 alpha map kinase complexed with a benzothiazole based inhibitor |
|
61
|
275
|
3c4cA |
B-raf kinase in complex with plx4720 |
|
90
|
317
|
3c0gA |
Cask cam-kinase domain- 3'-amp complex, p1 form |
|
69
|
307
|
3ce3A |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a pyrrolopyridinepyridone based inhibitor |
|
162
|
504
|
3c50A |
Crystal structure of g protein coupled receptor kinase 1 bound to adp and magnesium chloride at 2.6a |
|
89
|
302
|
3c4fA |
Fgfr tyrosine kinase domain in complex with 3-(3-methoxybenzyl)-7-azaindole |
|
96
|
298
|
3c0iA |
Cask cam-kinase domain- 3'-amp complex, p212121 form |
|
91
|
276
|
3bz3A |
Crystal structure analysis of focal adhesion kinase with a methanesulfonamide diaminopyrimidine inhibitor |
|
94
|
356
|
3cgoA |
Irak-4 inhibitors (part ii)- a structure based assessment of imidazo[1,2 a]pyridine binding |
|
104
|
376
|
3cd3A |
Crystal structure of phosphorylated human feline sarcoma viral oncogene homologue (v-fes) in complex with staurosporine and a consensus peptide |
|
155
|
504
|
3c4xA |
Crystal structure of g protein coupled receptor kinase 1 bound to atp and magnesium chloride at 2.9a |
|
77
|
311
|
3c1xA |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a pyrrolotriazine based inhibitor |
|
90
|
272
|
3bymA |
X-ray co-crystal structure aminobenzimidazole triazine 1 bound to lck |
|
85
|
293
|
3cd8A |
X-ray structure of c-met with triazolopyridazine inhibitor. |
